News | Cardiovascular Ultrasound | March 13, 2018

Siemens Healthineers Introduces Portable Cardiovascular-Dedicated Ultrasound at ACC.18

System addresses increasing demand for quality echo exams in more locations and fast-paced clinical environments

Siemens Healthineers Introduces Portable Cardiovascular-Dedicated Ultrasound at ACC.18

March 13, 2018 — At the American College of Cardiology’s (ACC) 67th Annual Scientific Session and Expo, March 10-12 in Orlando, Fla., Siemens Healthineers launched its new portable cardiovascular ultrasound solution, the Acuson Bonsai.

According to a recent study, 34 million echo exams were performed in the U.S. in 2017.1 The Acuson Bonsai addresses the challenge of these increased clinician workloads by providing a portable and quick system, while maintaining high-quality imaging and diagnostic confidence through user-friendly applications. The system was created together with Mindray Medical International Ltd.

In one portable system, the Acuson Bonsai provides one-touch image optimization and advanced imaging. The system automatically optimizes the ultrasound image with the touch of a button, eliminating the need for manual optimization on the part of the sonographer for improved workflow and image quality consistency. The system also utilizes advanced imaging to optimize specific to routine echocardiograms and cardiovascular workflows.

The Acuson Bonsai is compatible with a comprehensive set of 14 transthoracic echo (TTE) and transesophageal echo (TEE) transducers.

The system comes fully loaded with a complete set of user-friendly cardiology applications for fast and easy handling of routine echo exams. Included applications such as “Auto EF” for semi-automatic ejection fraction measurements and “Auto IMT” for automatic intima-media thickness measurements help clinicians acquire measurements in one click, which enables quicker exams and consistent and reproducible results.

The ultra-portable and ergonomic user design of the Acuson Bonsai’s laptop and mobile cart system offers flexibility in scanning locations. The laptop is over 1.7 cm thinner than the industrial average, according to Siemens, and its companion cart has a slim design and small footprint for maneuverability. Automated protocols reduce scan times up to 43 percent2 and reduce keystrokes up to 75 percent2, improving workflows and patient throughput. Raw Data capabilities on the system can also improve scan times and allow for flexibility with image optimization and measurements after the acquisition.

For more information: www.usa.healthcare.siemens.com

References

1. Arlington Medical Research, Echo monitor report 2017

2. The Role of a Protocol Management Feature in Improving Ultrasound Lab Efficiency, 2016

 

Related Content

American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair

Image courtesy of Massachusetts General Hospital

News | ACC | October 08, 2019
Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC)...
SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the a

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the late
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Overlay Init